Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epclusa in HCV-negative recipients of HCV-infected kidneys
NCT04075916Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Jun 2021
- Primary completion
- Jul 2025
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of velpatasvir in hepatitis C (HCV), sponsored by University of Pennsylvania. Started Jun 2021; status: completed.
02
Drugs
velpatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT04075916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04075916.